Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Æó¼â¼º Ȳ´Þ ¹× ±Þ¼º ´ãµµ¿° ȯÀÚ¿¡¼­ ´Ü±â°£ÀÇ ´ãÁó ¹è¾×ÀÌ Ç÷û ¹× ´ãÁóÀÇ Carcinoembryonic Antigen°ú CA19-9¿ù Áø´ÜÀû °¡Ä¡¿¡ ¹ÌÄ¡´Â ¿µÇâ Effect of Biliary Drainage on the Diagnostic Values of Serum and Bile CEA and CA19-9 in Patients with Obstructive Jaundice anchor Acute Cholangitis

´ëÇѼÒÈ­±âÇÐȸÁö 1998³â 32±Ç 6È£ p.792 ~ 801
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶Çö±Ù Á¤ÁØÇ¥/¹ÚÈ¿Áø/ÀÌ°ü½Ä/Á¤À纹/ÀüÀçÀ±/ÀÌ»óÀÎ/¹®¿µ¸í/°­Áø°æ

Abstract

¿ä¾à
¸ñÀû : Ç÷û Carcinoembryonic antigen (CEA)°ú CA19-9Àº ÃéÀå ¹× ´ãµµ°èÀÇ ¾Ç¼º ÁúȯÀÇ
Áø´Ü¿¡ ¸¹ÀÌ ÀÌ¿ëµÇ°í ÀÖÀ¸³ª, Æó¼â¼º Ȳ´ÞÀ̳ª ±Þ¼º ´ãµµ¿°ÀÌ ÀÖ´Â °æ¿ì¿¡´Â ¾ç¼º Áúȯ¿¡
¼­µµ Áõ°¡ÇÒ ¼ö ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ°í ÀÖÀ¸¸ç, ´ãÁó CEA¿Í CA19-9ÀÇ Áø´ÜÀû °¡Ä¡¿¡´Â ¾Æ
Á÷ ÀÌ°ßÀÌ ÀÖ´Ù. º» ¿¬±¸¿¡¼­´Â Æä¼â¼º Ȳ´Þ ¹× ±Þ¼º ´ãµµ¿°À¸·Î ³»¿øÇÏ¿© ´ãÁó ¹è¾×À» ÇÊ
¿ä·Î ÇÑ È¯Àڵ鿡 À־, ´ãÁó ¹è¾× ÈÄ ½Ã°£ÀÌ °æ°úÇÔ¿¡ µû¶ó Ç÷û ¹× ´ãÁóÀÇ CEA¿Í
CA19-9Ä¡°¡ º¯µ¿ÇÏ´ÂÁö¸¦ ¾Ë¾Æº¸°í, ±×·³À¸·Î½á ÀÏÁ¤ ½Ã°£ ÈÄ Ãé-´ãµµ°èÀÇ ¾ç-¾Ç¼º ÁúȯÀ»
°¨º°ÇÏ´Â Áø´Ü´ÉÀÌ Çâ»óµÇ´ÂÁö¸¦ ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý : Æó¼â¼º Ȳ´Þ ¹× ±Þ¼º ´ãµµ¿°À¸·Î ³»¿øÇÏ¿© ³»½Ã°æÀû ºñ´ãµµ ¹è¾×¼ú ¶Ç´Â
°æÇÇ°æ°£ ´ãµµ¹è¾×¼úÀ» ½ÃÇà¹ÞÀº ȯÀÚ 37¿¹(¾ç¼º Áúȯ±º 13¿¹, ¾Ç¼º Áúȯ±º 24¿¹)¸¦ ´ë»óÀ¸
·Î Ç÷û ¹× ´ãÁó¿¡¼­ CEA¿Í CA19-9À» ´ãÁó¹è¾×¼ú ½ÃÇà Àü ¶Ç´Â ´ç½Ã, ¹è¾× 2ÀÏ ÈÄ ¹× 7ÀÏ
ÈÄ¿¡ °¢°¢ ELISA ¹ýÀ¸·Î ÃøÁ¤ÇÏ¿´´Ù.
°á°ú : ´ãÁó ¹è¾×¿¡ ÀÇÇØ Ç÷û CEA´Â ¾ç¼º ¹× ¾Ç¼º Áúȯ±º¿¡¼­ º¯µ¿ÇÏÁö ¾Ê¾ÒÀ¸³ª, ¹è¾×
2ÀÏ ÈĺÎÅÍ Æ¯À̵µ¿Í ¾ç¼º ¿¹Ãøµµ°¡ Áõ°¡µÇ¾ú°í(°¢°¢ 84.6%¿¡¼­ 92.3%, 86.7%¿¡¼­ 90.0%),
¿¹¹Îµµ, À½¼º ¿¹Ãøµµ ¹× Á¤È®µµ´Â °¨¼ÒÇÏ¿´´Ù(°¢°¢ 54.2%¿¡¼­ 37.5%, 50.0%¿¡¼­ 44.4% ¹×
64.9%¿¡¼­ 56.8%). Ç÷û CA19-9Àº ¹è¾× 7ÀÏ ÈÄ¿¡ ¾ç¼º Áúȯ±º¿¡¼­ À¯ÀÇÇÏ°Ô °¨¼ÒµÇ¾î
(p=0.0018) ƯÀ̵µ, ¾ç¼º ¿¹Ãøµµ, À½¼º ¿¹Ãøµµ ¹× Á¤È®µµ°¡ Çâ»óµÇ¾úÀ¸³ª(°¢°¢ 7.7%¿¡¼­
46.2%, 65.7%¿¡¼­ 75.9%, 50.0%¿¡¼­ 75.0% ¹× 64.9%¿¡¼­ 75.7%), ¿¹¹Îµµ´Â 95.8%¿¡¼­
91.7%·Î ¾à°£ °¨¼ÒÇÏ¿´´Ù. ´ãÁó CEA¿Í CA19-9Àº ´ãÁó ¹è¾× Àü ¹× ÈÄ¿¡ À¯ÀÇÇÑ º¯µ¿ÀÌ ¾ø
¾ú°í, °¢ ½ÃÁ¡¿¡¼­ ¾ç¼º ¹× ¾Ç¼º Áúȯ±º°£ÀÇ Â÷À̵µ ¾ø¾ú´Ù.
°á·Ð : ´ãÁó ¹è¾×Àº Ç÷û CEA¹× CA19-9ÀÇ Áø´Ü´É¿¡ ¿µÇâÀ» ¹ÌÄ¡³ª, °¢ Á¾¾çÇ¥ÁöÀÚ¸¦ ´Ü
µ¶À¸·Î ÀÓ»ó¿¡ »ç¿ëÇÒ ¼ö ÀÖÀ» ¸¸Äñ Á¤È®µµ¸¦ Çâ»ó½ÃÅ°Áö ¸øÇϱ⠶§¹®¿¡, Ç÷û CEAÀÇ ³ôÀº
ƯÀ̵µ¿Í Ç÷û CA19-9ÀÇ ³ôÀº ¿¹¹Îµµ¸¦ °í·ÁÇÏ¿© °ø½ÄÀ» ¸¸µé¸é ÀÓ»ó¿¡ À¯¿ëÇÑ ÁöÇ¥¸¦ ¸¸
µé ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢µÇ¸ç, ´ãÁó CEA¿Í CA19-9Àº ºñ±³Àû ªÀº ±â°£ µ¿¾ÈÀÇ ´ãÁó ¹è¾×¿¡
ÀÇÇؼ­´Â ¿µÇâÀ» ¹ÞÁö ¾Ê¾Ò°í Áø´ÜÀû °¡Ä¡µµ ¾ø¾ú´Ù.
#ÃÊ·Ï#
Background/Aims : It is controversial to use serum cartinoembryonic antigen (CEA),
serum CA 19-9, bile CEA, and bile CA19-9 in diagnosing malignant pancreaticobiliary
diseases. The aim of this study was to determine whether a short-term biliary drainage
affects the values of serum CEA, serum CA19-9, bile CEA, and bile CA19-9 and thus,
improves diagnostic values.
Methods : Thirteen patients with benign causes of obstructive jaundice and/or acute
cholangitis and 24 patients with malignant causes were examined. All patients
underwent endoscopic or percutaneous biliary drainage. Serum and bile samples were
obtained at the time of biliary drainage procedure and at 2 and 7 days of post-drainage.
Then, the values of CEA and CA19-9 were measured.
Results : Biliary drainage did not change serum CEA in benign and malignant diseases.
The specificity and positive predictive value (PPV) of serum CEA were increased after
drainage, whereas its sensitivity, negative predictive value (NPV), and accuracy were
decreased. Serum CA19-9 was significantly decreased at 7 days of post-drainage in
benign diseases (p=0.0018). The specificity, PPV, NPV, and accuracy of serum CA 19-9
increased after drainage, whereas its sensitivity was decreased. The values of bile CEA
and CA19-9 were not affected by ciliary drainage and showed no difference between
benign and malignant diseases.
Conclusions : Biliary drainage affects the diagnostic valves of serum CEA and CA19-9.
Bile CEA and CA19-9 have no diagnostic roles.

Å°¿öµå

CEA; CA19-9; Æó¼â¼º Ȳ´Þ; ±Þ¼º ´ãµµ¿°; ´ãÁó ¹è¾×; CEA; CA19-9; Biliary drainage;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS